BLCO - Bausch & Lomb Corp
15.35
0.160 1.042%
Share volume: 278,286
Last Updated: 03-14-2025
Medical Equipment/Ophthalmic Goods:
0.01%
PREVIOUS CLOSE
CHG
CHG%
$15.19
0.16
0.01%
View ratios
| Fiscal Date | 12-31-2023 | 12-31-2023 | 03-31-2024 | 03-31-2024 | 06-30-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2023 | Q4 2023 | Q1 2024 | Q1 2024 | Q2 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 10-30-2024 | 02-21-2024 | 05-01-2024 | 05-01-2024 | 08-01-2024 | 08-01-2024 | 10-30-2024 | 02-19-2025 | |
| Assets | |||||||||
| Total Assets | 13.442 B | 13.442 B | 13.293 B | 13.293 B | 13.250 B | 13.250 B | 13.515 B | 13.469 B | |
| Current Assets | 2.742 B | 2.742 B | 2.743 B | 2.743 B | 2.769 B | 2.769 B | 2.828 B | 2.788 B | |
| Inventories | 1.028 B | 1.028 B | 1.073 B | 1.073 B | 1.069 B | 1.069 B | 1.119 B | 1.036 B | |
| Other Current Assets | 0.000 | 541.000 M | 0.000 | 425.000 M | 0.000 | 412.000 M | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 541.000 M | 0.000 | 425.000 M | 0.000 | 412.000 M | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 839.000 M | 0.000 | 920.000 M | 0.000 | 986.000 M | 0.000 | 0.000 | |
| Current Cash | 331.000 M | 331.000 M | 315.000 M | 315.000 M | 285.000 M | 285.000 M | 329.000 M | 305.000 M | |
| Total Non-current Assets | 0.000 | 10.700 B | 0.000 | 10.550 B | 0.000 | 10.481 B | 0.000 | 0.000 | |
| Property Plant Equipment | 1.390 B | 1.390 B | 1.397 B | 1.397 B | 1.430 B | 1.430 B | 1.481 B | 1.485 B | |
| Other Assets | 9.310 B | 225.000 M | 9.153 B | 231.000 M | 9.051 B | 249.000 M | 9.206 B | 9.196 B | |
| Intangible Assets | 0.000 | 3.589 B | 0.000 | 3.515 B | 0.000 | 3.437 B | 0.000 | 0.000 | |
| Goodwill | 0.000 | 4.575 B | 0.000 | 4.547 B | 0.000 | 4.538 B | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 13.442 B | 13.442 B | 13.293 B | 13.293 B | 13.250 B | 13.250 B | 13.515 B | 13.469 B | |
| Total liabilities | 6.522 B | 6.592 B | 6.564 B | 6.634 B | 6.670 B | 6.746 B | 6.854 B | 6.925 B | |
| Total current liabilities | 1.579 B | 1.579 B | 1.617 B | 1.617 B | 1.676 B | 1.676 B | 1.801 B | 1.738 B | |
| Accounts Payable | 522.000 M | 522.000 M | 426.000 M | 426.000 M | 405.000 M | 405.000 M | 455.000 M | 389.000 M | |
| Other liabilities | 397.000 M | 397.000 M | 379.000 M | 379.000 M | 378.000 M | 378.000 M | 442.000 M | 430.000 M | |
| Current long term debt | 0.000 | 30.000 M | 0.000 | 30.000 M | 0.000 | 30.000 M | 0.000 | 0.000 | |
| Long term debt | 4.532 B | 4.532 B | 4.554 B | 4.554 B | 4.602 B | 4.602 B | 4.599 B | 4.744 B | |
| Other liabilities | 397.000 M | 397.000 M | 379.000 M | 379.000 M | 378.000 M | 378.000 M | 442.000 M | 430.000 M | |
| Minority interest | 0.000 | 70.000 M | 0.000 | 70.000 M | 0.000 | 76.000 M | 0.000 | 0.000 | |
| Total Shareholder equity | 6.850 B | 6.850 B | 6.659 B | 6.659 B | 6.504 B | 6.504 B | 6.589 B | 6.473 B | |
| Common stock | 8.349 B | 351.200 M | 8.363 B | 351.100 M | 8.382 B | 351.800 M | 8.405 B | 8.429 B | |
| Retained earnings | -254.000 M | -254.000 M | -421.000 M | -421.000 M | -572.000 M | -572.000 M | -568.000 M | -571.000 M |